← Back to Search

Robotic vs. Video-Assisted Thoracic Surgery for Early Stage Lung Cancer

N/A
Recruiting
Led By Waël C Hanna, MDCM, MBA, FRCSC
Research Sponsored by St. Joseph's Healthcare Hamilton
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >/= 18 years
Clinical stage I, II or IIIa non-small cell lung cancer (NSCLC)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years post-surgery
Awards & highlights

Study Summary

This trial will help determine if robotic technology is better than traditional methods for early stage lung cancer surgery.

Who is the study for?
This trial is for adults over 18 with early-stage lung cancer (stage I, II or IIIa) who are candidates for minimally invasive lung surgery. It's not suitable for those with more advanced stage IIIb or IV cancer, or those who can't have minimally invasive procedures.Check my eligibility
What is being tested?
The study compares two types of minimally invasive lung surgery: video-assisted thoracoscopic lobectomy (VATS) and robotic thoracic surgery (RTS). Patients will be randomly assigned to receive either VATS, which uses a camera and small incisions, or RTS, which employs precise instruments and 3D imaging.See study design
What are the potential side effects?
While the trial description does not specify side effects, both surgical methods may include risks such as bleeding, infection at the incision site, pain after operation, prolonged air leak from lungs or general complications related to surgeries.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
My lung cancer is at an early to mid-stage (I, II, or IIIa).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years post-surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years post-surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in HRQOL scores at week 12 between the treatment groups
Secondary outcome measures
Cost Effectiveness
Difference in 5-year survival rate between the two groups
Difference in HRQOL scores between the treatment groups
+2 more

Trial Design

2Treatment groups
Active Control
Group I: Thoracoscopic LobectomyActive Control1 Intervention
Group II: Robotic LobectomyActive Control1 Intervention

Find a Location

Who is running the clinical trial?

St. Joseph's Healthcare HamiltonLead Sponsor
196 Previous Clinical Trials
24,952 Total Patients Enrolled
1 Trials studying Thoracic Surgery
University of Toronto / Toronto General HospitalUNKNOWN
University of FloridaOTHER
1,341 Previous Clinical Trials
715,075 Total Patients Enrolled

Media Library

Robotic thoracic surgery Clinical Trial Eligibility Overview. Trial Name: NCT02617186 — N/A
Thoracic Surgery Research Study Groups: Thoracoscopic Lobectomy, Robotic Lobectomy
Thoracic Surgery Clinical Trial 2023: Robotic thoracic surgery Highlights & Side Effects. Trial Name: NCT02617186 — N/A
Robotic thoracic surgery 2023 Treatment Timeline for Medical Study. Trial Name: NCT02617186 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this experiment still open?

"According to records published on clinicaltrials.gov, this experiment is still recruiting patients. The initial post was made in January 2016 and the trial was recently updated in November 2022."

Answered by AI

How many participants are being recruited for this medical experiment?

"Indeed, clinicaltrials.gov indicates that this trial is actively recruiting participants. It was first listed on January 1st 2016 and the most recent update occurred on November 2nd 2022. The study requires a total of 592 patients from one facility to be enrolled in order to commence its research agenda."

Answered by AI
Recent research and studies
The Annals of Thoracic SurgeryJournal
Performing Robotic Lobectomy and Segmentectomy: Cost, Profitability, and Outcomes
Nasir, Basil S., Ayesha S. Bryant, Douglas J. Minnich, Ben Wei, and Robert J. Cerfolio. 2014. “Performing Robotic Lobectomy and Segmentectomy: Cost, Profitability, and Outcomes”. The Annals of Thoracic Surgery. Elsevier BV. doi:10.1016/j.athoracsur.2014.02.051.
Thoracic Surgery ClinicsJournal
Thoracoscopic Versus Robotic Approaches
Wei, Benjamin, and Thomas A. D’Amico. 2014. “Thoracoscopic Versus Robotic Approaches”. Thoracic Surgery Clinics. Elsevier BV. doi:10.1016/j.thorsurg.2014.02.001.
The Annals of Thoracic SurgeryJournal
Lymph Node Evaluation Achieved by Open Lobectomy Compared with Thoracoscopic Lobectomy for N0 Lung Cancer
Merritt, Robert E., Chuong D. Hoang, and Joseph B. Shrager. 2013. “Lymph Node Evaluation Achieved by Open Lobectomy Compared with Thoracoscopic Lobectomy for N0 Lung Cancer”. The Annals of Thoracic Surgery. Elsevier BV. doi:10.1016/j.athoracsur.2013.05.044.
The Journal of Thoracic and Cardiovascular SurgeryJournal
Robotic Lobectomy for Non–small Cell Lung Cancer (NSCLC): Long-term Oncologic Results
Park, Bernard J., Franca Melfi, Alfredo Mussi, Patrick Maisonneuve, Lorenzo Spaggiari, Ruy Kuenzer Caetano Da Silva, and Giulia Veronesi. 2012. “Robotic Lobectomy for Non–small Cell Lung Cancer (NSCLC): Long-term Oncologic Results”. The Journal of Thoracic and Cardiovascular Surgery. Elsevier BV. doi:10.1016/j.jtcvs.2011.10.055.
~64 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top